Patient Stories
-
VANESSA G.
I advocate strongly for the under 50 crowd and for those of us who do not have family history.
-
ISMAIL A.
I have undergone 6 months of chemotherapy and now on my road to fitness with a half marathon planned for March 2014.
-
DEBBIE W.
I had a grandson that was just born and I had never met, and I was determined that no matter how much or how little cancer I had, it was not going to defeat me.
What’s New
Bristol-Myers Squibb’s Opdivo ® (nivolumab) + Low- Dose Yervoy ® (ipilimumab) is the First Immuno-Oncology Combination Approved for MSI-H/dMMR mCRC Patients Who Progressed Following Treatment with a Fluoropyrimidine, Oxaliplatin and Irinotecan
EVENTS
Michael’s Mission 8th Annual Benefit
An Evening Honoring
Donna M. Introcaso-Allison, Founder and CEO IntroInc.
2017 LEADERSHIP AWARD
In Memory of Kristen R. McRedmond-Hope Award Patient Advocacy
& Joseph Orlando-Hope Award Patient Mentorship
Karen Walsh-Hope Award Patient Outreach & Awareness
8th Annual Gala E-Journal